Prevalence of new psychoactive substances in oral fluid samples from French drivers

A longitudinal survey (2016–2020)
Author(s)
Richeval, C.; Gish, A.; Hakim, F.; Nachon-Phanithavong, M.; Wiart, J.-F.; Humbert, L.; Allorge, D.; Gaullier, J.-M.
Year

Currently, standard roadside testing in France is performed in oral fluid (OF) using an on-site immunological screening for drugs of abuse (DOA), specifically the Drugwipe-5S® from Securetec (OF screening test for ecstasy/amphetamine, opiates, cocaine and cannabis). In 2016 and in 2017, we tested French and Belgian drivers’ OF samples for new psychoactive substances (NPS) after a positive or negative roadside screening test for DOA. Here, we complete these data by updated results in French drivers’ OF sampled in 2018, 2019 and 2020.

Request publication

1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Pages
e20-e21
Published in
Journal of Analytical Toxicology
45 (6)
Library number
20220003 ST [electronic version only]

Our collection

This publication is one of our other publications, and part of our extensive collection of road safety literature, that also includes the SWOV publications.